Related Experiment Videos

[Comparison between two antibiotic schemes in relation to surgical site infection in children: a randomized clinical

Eduardo Bracho-Blanchet1, Juan Porras-Hernández, Roberto Dávila-Pérez

  • 1Departamento de Cirugía General, Hospital Infantil de México "Federico Gómez", México, D.F., Mexico. eduardo@fambracho.org

Cirugia Y Cirujanos
|November 19, 2009
PubMed

Insights

Short-term antibiotic prophylaxis (AP) given 2 hours before surgery significantly reduced surgical site infections (SSIs) in pediatric clean-contaminated procedures compared to traditional multi-day antibiotic regimens.

Area of Science:

  • Pediatric Surgery
  • Infectious Disease Prevention
  • Clinical Trials

Background:

  • Limited randomized clinical trials exist on antibiotic prophylaxis (AP) effectiveness for preventing pediatric surgical site infections (SSIs).
  • This study aimed to compare AP effectiveness against traditional antibiotic schemes.

Purpose of the Study:

  • To evaluate the efficacy of a 24-hour antibiotic prophylaxis regimen versus a 5-day traditional antibiotic scheme in preventing SSIs in pediatric patients.

Main Methods:

  • A randomized clinical trial was conducted with 187 pediatric patients (≤18 years) undergoing clean or clean-contaminated procedures.
  • The experimental group received 24-hour AP (cefalotin or clindamycin plus amikacin) starting 2 hours pre-incision.
  • The control group received a 5-day traditional antibiotic regimen.

Main Results:

  • The experimental group showed a significantly lower SSI incidence (1.2%) compared to the control group (10.9%) (RR 9.7, p=0.009).
  • This reduction was primarily observed in clean-contaminated procedures.
  • Sixteen patients were excluded from the analysis.

Conclusions:

  • Administering antibiotic prophylaxis 2 hours before incision and continuing for 24 hours significantly reduces SSI risk in pediatric clean-contaminated procedures.
  • This short-term AP regimen is more effective than traditional 5-day antibiotic schemes for preventing SSIs in this patient group.
Abstract

Related Concept Videos

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...